Taken together, different studies with RKIP-transgenic mice and RKIP knockout mice demonstrate that RKIP accelerates and/or promotes symptoms of cardiac dysfunction, heart failure and cardiac fibrosis in vivo [11,21,22,23]. This evidence concerns the gene PEBP1 and heart failure.